a 2545 has been researched along with dihydrolipoamide in 1 studies
*dihydrolipoamide: RN given refers to cpd without isomeric designation [MeSH]
*dihydrolipoamide: RN given refers to cpd without isomeric designation [MeSH]
Studies (a 2545) | Trials (a 2545) | Recent Studies (post-2010) (a 2545) | Studies (dihydrolipoamide) | Trials (dihydrolipoamide) | Recent Studies (post-2010) (dihydrolipoamide) |
---|---|---|---|---|---|
9 | 1 | 0 | 45 | 0 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czopf, L; Deres, P; Habon, T; Halmosi, R; Hideg, K; Kalai, T; Kovacs, K; Palfi, A; Sumegi, B; Toth, A; Toth, K | 1 |
1 other study(ies) available for a 2545 and dihydrolipoamide
Article | Year |
---|---|
Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Cell Line, Tumor; Doxorubicin; Energy Metabolism; Free Radical Scavengers; Humans; In Vitro Techniques; Indoles; Lipid Peroxidation; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Myocardium; Oxidation-Reduction; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Thioctic Acid | 2005 |